Drug Type Small molecule drug |
Synonyms Rapicol Care, 래피콜케어건조시럽 |
Action inhibitors, antagonists, agonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (28 May 2025), |
Regulation- |
Molecular FormulaC6H8O6 |
InChIKeyCIWBSHSKHKDKBQ-JLAZNSOCSA-N |
CAS Registry50-81-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | South Korea | 28 May 2025 |